勘误：高级卵巢癌的无进展生存期：加拿大的回顾和专家小组观点。
Erratum: Corrigendum: Progression-free survival in advanced ovarian cancer: a Canadian review and expert panel perspective.
出版信息
Curr Oncol. 2011 Dec;18(6):303.
Abstract
[This corrects the article on p. S20 in vol. 18, PMID: 21969808.].
摘要
[这篇文章更正了第 18 卷第 S20 页的内容，PMID：21969808。]
相似文献
1
Erratum: Corrigendum: Progression-free survival in advanced ovarian cancer: a Canadian review and expert panel perspective.
Curr Oncol. 2011 Dec;18(6):303.
2
Corrigendum.
Paediatr Child Health. 2015 Nov-Dec;20(8):466-7. doi: 10.1093/pch/20.8.466.
3
ERRATUM.
Int J Bioprint. 2020 Sep 17;6(4):309. doi: 10.18063/ijb.v6i4.309. eCollection 2020.
4
Erratum: Corrigendum: Survival and treatment patterns in elderly patients with advanced non-small-cell lung cancer in Manitoba.
Curr Oncol. 2012 Feb;19(1):e42. doi: 10.3747/co.19.1012.
5
Erratum: B-cell-specific Moloney murine leukemia virus integration site 1: potential stratification factor and therapeutic target for epithelial ovarian cancer [Corrigendum.
Onco Targets Ther. 2017 Apr 27;10:2323. doi: 10.2147/OTT.S139588. eCollection 2017.
6
Erratum: Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian carcinoma during the drug shortage era [Corrigendum].
Onco Targets Ther. 2015 Mar 9;8:593. doi: 10.2147/OTT.S80592. eCollection 2015.
7
Erratum: Effect of first-line endocrine therapy in patients with hormone-sensitive advanced breast cancer: a network meta-analysis [Corrigendum].
Onco Targets Ther. 2018 Jul 31;11:4449. doi: 10.2147/OTT.S179985. eCollection 2018.
8
Erratum: corrigendum.
Clin Ophthalmol. 2011;5:1557. doi: 10.2147/OPTH.S27293. Epub 2011 Oct 31.
9
Corrigendum.
J Cachexia Sarcopenia Muscle. 2015 Jun;6(2):192. doi: 10.1002/jcsm.12038.
10
Erratum: Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction [Corrigendum].
Clin Ophthalmol. 2017 May 11;11:887. doi: 10.2147/OPTH.S138482. eCollection 2017.
Zotero 插件